Efficacy and safety of oxycodone/naloxone as add-on therapy to gabapentin or pregabalin for the management of chemotherapy-induced peripheral neuropathy in Korea.
Bong-Seog KimJong-Youl JinJung Hye KwonIn Sook WooYoon Ho KoSuk-Young ParkHye-Jeong ParkJin-Hyoung KangPublished in: Asia-Pacific journal of clinical oncology (2017)
Oxycodone/naloxone added to pregabalin or gabapentin provided additional pain relief and symptom control in Korean patients with CIPN, without clinically significant safety concerns.